Skip to main content
SpringerLink
Log in

Alectinib/bosutinib/osimertinib

Cardiac dysfunctions: 45 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Identifying patient details of two patients have been obtained through direct communication with the author.

Reference

  • Mizuno T, et al. Identification of target small molecule tyrosine kinase inhibitors that need monitoring and clinical application of protocol for early detection of cancer therapeutics-related cardiac dysfunction using signal detection: An investigation of real world data. Journal of Oncology Pharmacy Practice 27: 804-814, No. 4, Jun 2021. Available from: URL: http://doi.org/10.1177/1078155220930367

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib/bosutinib/osimertinib. Reactions Weekly 1866, 24 (2021). https://doi.org/10.1007/s40278-021-99720-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-99720-8

Search

Navigation